Background: Though the advent of highly active anti-retroviral medications has improved survival in HIV infection, mortality from non-infectious complications such as pulmonary arterial hypertension (PAH) has increased. Also, studies have shown that PAH is the leading cause of hospitalization and death in patients with HIV associated PAH (HIV-PAH). However, not much is known about the [...]

Case Presentation: Systemic lupus erythematosus (SLE), commonly known as lupus, is a multifaceted autoimmune disorder characterized by a myriad of clinical manifestations, including but not limited to fatigue, joint pain and swelling, and malar rash. Although a common cardiac manifestation of SLE is pericarditis, often accompanied by pericardial effusion, pulmonary arterial hypertension (PAH) is not [...]

Case Presentation: A 72 year old male presented with worsening shortness of breath and increasing oxygen requirement for six weeks. The patient had been on supplemental oxygen for the past 2 years for hypoxia. As an outpatient, right heart catheterization revealed a pulmonary arterial pressure (PAP) of 76/24 mmHg, mean PAP of 41 mmHg, wedge [...]

Case Presentation: Pulmonary hypertension (PH) affects 1% of the global population, including 10% of people over 65 and ~50% of people with Congestive Heart Failure (CHF). Pulmonary hypertension (PH) is classified into 5 clinical subgroups: pulmonary arterial hypertension (PAH), PH due to left-sided heart disease, PH due to chronic lung disease, PH due to chronic [...]